Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.170
-0.070 (-5.65%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Indaptus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
8.918.768.595.210.940.54
Research & Development
7.577.626.322.522.662.09
Operating Expenses
16.4816.3814.917.733.62.63
Operating Income
-16.48-16.38-14.91-7.73-3.6-2.63
Other Non Operating Income (Expenses)
0.730.960.590.020.020.07
Pretax Income
-15.75-15.42-14.32-7.71-3.58-2.57
Net Income
-15.75-15.42-14.32-7.71-3.58-2.57
Net Income to Common
-15.75-15.42-14.32-7.71-3.58-2.57
Shares Outstanding (Basic)
888421
Shares Outstanding (Diluted)
888421
Shares Change (YoY)
1.37%1.68%101.98%110.35%165.44%-
EPS (Basic)
-1.86-1.84-1.73-1.89-1.84-3.50
EPS (Diluted)
-1.86-1.84-1.73-1.89-1.84-3.50
Free Cash Flow
-12.75-13.41-13.08-11.29-3.32-2.13
Free Cash Flow Per Share
-1.51-1.60-1.58-2.76-1.71-2.91
EBITDA
-16.48-16.38-14.91-7.73-3.6-2.63
D&A For EBITDA
000000
EBIT
-16.48-16.38-14.91-7.73-3.6-2.63
Source: S&P Capital IQ. Standard template. Financial Sources.